New era for ME/CFS research as top cytokine study attracts media headlines
The immune systems of patients who have recently developed ME/CFS look markedly different from those who have been ill for much longer, according to a major new study from Drs. Ian Lipkin and Mady Hornig at Columbia University. This shift in immune function hadn’t been seen before.
Discuss the article on the Forums.

Alzheimers: Psoriasis drug 'slows dementia' mice study suggests

Discussion in 'General Treatment' started by MishMash, Nov 26, 2012.

  1. MishMash

    MishMash *****

    Messages:
    445
    Likes:
    487
    Georgia
    A commonly used anti-psoriasis drug in Europe is being used to make BG-12, Biogen's soon-to-be-approved MS drug. http://www.ncbi.nlm.nih.gov/pubmed/22992073. Reason for hope for sufferers of all neuroimmune disorders.

    It seems the same psoriasis compound is being tested to control Alzheimer's:

     
    Little Bluestem and merylg like this.

See more popular forum discussions.

Share This Page